CADONILIMAB

Clinical trials for CADONILIMAB explained in plain language.

Never miss a new study

Get alerted when new CADONILIMAB trials appear

Sign up with your email to follow new studies for CADONILIMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Drug combo helps High-Risk kidney cancer patients avoid full kidney removal

Disease control Completed

This study tested a combination of two drugs (cadonilimab and lenvatinib) given before surgery to 39 people with kidney cancer that was difficult to operate on. The goal was to shrink the tumor enough so that only the cancerous part of the kidney could be removed, sparing the res…

Matched conditions: CADONILIMAB

Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated May 26, 2026 11:03 UTC

CADONILIMAB

Get alerted when new CADONILIMAB trials appear

Drug combo helps High-Risk kidney cancer patients avoid full kidney removal